טוען...
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
Here, we review the role of pituitary adenylate cyclase-activating peptide-38 (PACAP38) in migraine pathophysiology and data implicating PAC(1) receptor as a future drug target in migraine. Much remains to be fully elucidated about migraine pathophysiology, but recent attention has focused on signal...
שמור ב:
| הוצא לאור ב: | Neurotherapeutics |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935633/ https://ncbi.nlm.nih.gov/pubmed/29464574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0596-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|